Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives-Reference-Cited by-同舟云学术

Triorganotin complexes in cancer chemotherapy: Mechanistic insights and future perspectives

Published:2020-11-10 Issue:2 Volume:35 Page:
ISSN:0268-2605
Container-title:Applied Organometallic Chemistry
language:en
Short-container-title:Appl Organomet Chem

Author:

Anasamy Theebaa¹^ORCID,Chee Chin Fei²,Wong Yuen Fei³,Heh Choon Han¹,Kiew Lik Voon⁴,Lee Hong Boon¹⁵,Chung Lip Yong¹^ORCID

Affiliation:

1. Department of Pharmaceutical Chemistry, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia

2. Nanotechnology and Catalysis Research Centre University of Malaya Kuala Lumpur Malaysia

3. Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmacy University of Malaya Kuala Lumpur Malaysia

4. Department of Pharmacology, Faculty of Medicine University of Malaya Kuala Lumpur Malaysia

5. School of Biosciences, Faculty of Health and Medical Sciences Taylor's University Subang Jaya Selangor Malaysia

Funder

Kementerian Pendidikan Malaysia

Publisher

Wiley

Subject

Inorganic Chemistry,General Chemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/aoc.6089

Reference183 articles.

1. Organo-tin antitumor compounds: Their present status in drug development and future perspectives

2. Developmental Therapeutic Program National Cancer Institute https://dtp.cancer.gov/dtpstandard/cancerscreeningdata/index.jsp (accessed 20th April 2020).

3. Exploration of organotin(IV) derivatives for medicinal applications: Synthesis, spectroscopic characterization, structural elucidation and molecular docking study

4. Biological activity studies on organotin(IV)n+ complexes and parent compounds

5. Toxicity and the cardiovascular activity of organotin compounds: a review

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer effect of organotin complexes derived from 2,6-naphthalenedicarboxylic acid by enhancing the ROS generation;Journal of Molecular Structure;2024-05

2. New Tin (IV) and Organotin (IV) Complexes with a Hybrid Thiosemicarbazone/Hydrazone Ligand: Synthesis, Crystal Structure, and Antiproliferative Activity;Bioinorganic Chemistry and Applications;2024-04-03

3. Organotin(IV)‐Decorated Graphene Quantum Dots as Dual Platform for Molecular Imaging and Treatment of Triple Negative Breast Cancer;Chemistry – A European Journal;2023-09-18

4. Syntheses, structures, and the in vitro anticancer mechanism of triorganotin (IV) complexes based on 4,4′‐stilbenedicarboxylic acid;Applied Organometallic Chemistry;2023-01-17

5. Corrigendum: Corrected funding statement;Applied Organometallic Chemistry;2022-11-17